TP53 and cancer: However, in PLC/PRF/5, the significant increase in p53, p21 and RB expression and the significant decrease in c-Myc, Cyclin D1 and MDM2 expression suggest a tumor suppressor effect of DKK1 on this cancer cell line through inhibition of the canonical pathway.